Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
about
Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts WorldwidePrognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryIndependent association of glucocorticoids with damage accrual in SLE.It hasn't gone away: the problem of glucocorticoid use in lupus remains.Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.A retrospective study of joint infections in patients with systemic lupus erythematosus.Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL.Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.Phagocyte activity in the peripheral blood of pregnant women with systemic lupus erythematosus and in the cord blood of their newborns.Long-term prognosis and factors associated with damage accrual in Japanese patients with systemic lupus erythematosus.Systemic lupus erythematosus.Lupus community panel proposals for optimising clinical trials: 2018.Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period.Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials
P2860
Q36192962-83F77B4D-7B90-4F8A-843D-E352C852163AQ36234766-0CECA3A6-4A34-49E4-9067-1671D50EC3B4Q36540787-D956D9F8-D6E1-479F-B2A2-DA40E5A8BFCBQ37464030-D7F07340-4913-45D1-BFD2-D0C8FFE7C148Q39053147-E2F5DB47-30D8-4081-AE32-1AB43F7230D4Q39792182-364E5A32-5C44-4EE6-8D24-28C83E58604EQ40049456-06CD45C8-073B-4445-925B-369040126484Q40126330-BBBE99EC-6768-4B17-8F92-7E88E0AC6B4CQ40156825-9169CCA5-CC37-436D-BFC3-3399506BCB65Q40621351-6B8985A0-B632-47E4-81E6-EED97158FE15Q40831626-726C5E7D-C5E4-4B0D-8B11-D3F0214C8DD6Q46373068-9E49C664-312B-40B2-A720-DE9C32435A84Q47233650-97B4EB3B-5805-41A7-AB24-7481B435405AQ50848358-2EE64F89-B288-4557-AF2A-1CB93B031DE1Q52320880-13B05616-422F-47C9-B93E-8E94BE009D6DQ52353641-ECAF9507-77C0-4F1A-AEAB-BD057F2936C6Q52561176-B412F331-76E6-4D98-8951-DA31D951B532Q54263409-F06CAF0D-22B6-4EBC-A6C0-2AC959B2A4B3Q55339985-3CBC50C6-CA3B-49AF-9304-6947F0A9A08CQ57495648-F8DCFC12-0F1E-46BD-826A-682B6999E939
P2860
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
@en
type
label
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
@en
prefLabel
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
@en
P2093
P2860
P356
P1433
P1476
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.
@en
P2093
Chee-Seng Yee
Deva Situnayake
Richard Hickman
Simon Bowman
Vernon Farewell
Veronica Toescu
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEU412
P577
2014-10-15T00:00:00Z